Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,758 | Dovepress* | 11,057+ | 1,931 | 12,988 | |
PubMed Central* | 2,701 | 481 | 3,182 | ||
Totals | 13,758 | 2,412 | 16,170 | ||
*Since 31 March 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar